PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsCeftaroline fosamil
Teflaro, Zinforo(ceftaroline fosamil)
Teflaro, Zinforo (ceftaroline fosamil) is a small molecule pharmaceutical. Ceftaroline fosamil was first approved as Teflaro on 2010-10-29. It is used to treat escherichia coli infections, infectious skin diseases, klebsiella infections, pneumonia, and staphylococcal infections amongst others in the USA. It has been approved in Europe to treat community-acquired infections, infectious skin diseases, and pneumonia.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
Teflaro (discontinued: Ceftaroline fosamil)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ceftaroline fosamil
Tradename
Company
Number
Date
Products
TEFLAROAbbVieN-200327 RX2010-10-29
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
teflaroNew Drug Application2024-11-20
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
pneumoniaEFO_0003106D011014—
infectious skin diseases—D012874—
escherichia coli infectionsEFO_1001318D004927B96.20
streptococcal infectionsEFO_1001476D013290—
staphylococcal infections—D013203A49.01
klebsiella infectionsEFO_1001353D007710—
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Ceftaroline Fosamil, Teflaro, Abbvie
82474002031-02-10DPU-282
96298612030-09-21DP
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01D: Other beta-lactam antibacterials in atc
— J01DI: Other cephalosporins and penems in atc
— J01DI02: Ceftaroline fosamil
HCPCS
Code
Description
J0712
Injection, ceftaroline fosamil, 10 mg
Clinical
No data
Drug
General
Drug common nameCeftaroline fosamil
INNceftaroline fosamil
Description
Ceftaroline fosamil acetate monohydrate is a hydrate that is the monohydrate form of ceftaroline fosamil acetate. A prodrug for ceftaroline, used for the treatment of adults with acute bacterial skin and skin structure infections. It has a role as an antimicrobial agent, an antibacterial drug and a prodrug. It contains a ceftaroline fosamil acetate.
Classification
Small molecule
Drug classcephalosporins; phosphoro-derivatives
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1
Identifiers
PDB—
CAS-ID229016-73-3
RxCUI—
ChEMBL IDCHEMBL501122
ChEBI ID70718
PubChem CID16007393
DrugBankDB06590
UNII ID7P6FQA5D21 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Teflaro – Allergan
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Teflaro – Warner Chilcott
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use